Market Cap
Santhera Pharmaceuticals Holding AG Market Capitalization:
CHF107.2 Million
CHF as of Jan. 1, 2024
US$127.3 Million
Santhera Pharmaceuticals Holding AG Main Stock Listing
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$461.52 B |
Vertex Pharmaceuticals Incorporated
|
$107.23 B |
|
Regeneron Pharmaceuticals, Inc.
|
$100.01 B |
CSL Limited
|
$94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$586.39 B |
|
UnitedHealth Group
|
$504.47 B |
|
Novo Nordisk
|
$461.52 B |
|
Johnson & Johnson
|
$387.50 B |
|
Merck
|
$296.51 B |
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Santhera Pharmaceuticals Holding AG Categories
Switzerland
languages
Healthcare
languages
Biotechnology
Switzerland Healthcare
Switzerland Biotechnology
Stocks & Indices
Santhera Pharmaceuticals Holding AG has the following listings and related stock indices.
Stock: SIX: SANN
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.